Matthew B Avison Selected Research

Infections

1/2024	Hound: a novel tool for automated mapping of genotype to phenotype in bacterial genomes assembled de novo.
1/2022	Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors.
10/2021	OmpF Downregulation Mediated by Sigma E or OmpR Activation Confers Cefalexin Resistance in Escherichia coli in the Absence of Acquired β-Lactamases.
1/2021	Trade-Offs between Antibacterial Resistance and Fitness Cost in the Production of Metallo-β-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting.
11/2017	Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates.
2/2002	Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew B Avison Research Topics

Disease

6	Infections 01/2024 - 02/2002
3	Urinary Tract Infections (Urinary Tract Infection) 03/2022 - 01/2020
1	Pain (Aches) 01/2024
1	Inflammation (Inflammations) 01/2024
1	Peritonitis 01/2022
1	Bacteriuria 11/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2021
1	Bacterial Pneumonia 12/2020
1	COVID-19 12/2020
1	Cross Infection (Nosocomial Infection) 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2019

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 02/2002
2	Meropenem (Merrem)FDA LinkGeneric 01/2022 - 01/2021
2	LactamsIBA 01/2019 - 11/2017
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2024
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2024
1	4-sulfophenylmethallyl ether (SPME)IBA 03/2022
1	MetalsIBA 03/2022
1	OxidesIBA 03/2022
1	FluoroquinolonesIBA 11/2021
1	Cephalexin (Cefalexin)FDA LinkGeneric 10/2021
1	Volatile Organic CompoundsIBA 11/2020
1	Third Generation CephalosporinsIBA 01/2020
1	Aztreonam FDA LinkGeneric 11/2017
1	avibactamIBA 11/2017
1	Vancomycin FDA LinkGeneric 02/2002
1	GlycopeptidesIBA 02/2002